Location History:
- Daejeon-si, KR (2009)
- Seoul, KR (2010)
- Daejeon, KR (2012)
Company Filing History:
Years Active: 2009-2012
Title: Innovations of Sukchan Lee in Neuroscience
Introduction
Sukchan Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of neuroscience, particularly in the development of therapeutic methods for mood disorders and seizure prevention. With a total of 3 patents, his work has the potential to impact the treatment of various neurological conditions.
Latest Patents
One of Sukchan Lee's latest patents is a composition for the prevention and treatment of absence seizures, which comprises a PKC agonist as an effective ingredient. This invention demonstrates that administering a PKC agonist can reduce absence seizure-specific SWD in animal models. The composition can be effectively utilized for both the prevention and treatment of absence seizures, as well as for the production of health-improving functional food.
Another notable patent involves therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels. This invention utilizes a novel mouse model deficient in alpha 1G T-type calcium channels, which exhibits enhanced novelty-seeking behavior and alcohol preference. This model can be instrumental in developing medicines and therapeutic methods for human nervous diseases, including anxiety and emotional disorders.
Career Highlights
Sukchan Lee is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work is characterized by a strong focus on understanding the underlying mechanisms of neurological disorders and finding innovative solutions to address them.
Collaborations
Sukchan Lee collaborates with notable colleagues, including Daesoo Kim and Jungryun Lee. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in the field of neuroscience.
Conclusion
Sukchan Lee's innovative work in neuroscience, particularly in the areas of seizure prevention and mood disorder treatments, showcases his commitment to improving health outcomes. His patents reflect a deep understanding of complex neurological mechanisms and offer promising avenues for future research and therapeutic development.